CVS Health Corporation $CVS Shares Bought by Atlas Brown Inc.

by · The Cerbat Gem

Atlas Brown Inc. increased its holdings in CVS Health Corporation (NYSE:CVS – Free Report) by 7.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,263 shares of the pharmacy operator’s stock after buying an additional 370 shares during the quarter. Atlas Brown Inc.’s holdings in CVS Health were worth $363,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of CVS. Persium Advisors LLC grew its stake in shares of CVS Health by 9.5% during the 2nd quarter. Persium Advisors LLC now owns 9,010 shares of the pharmacy operator’s stock worth $622,000 after purchasing an additional 785 shares during the period. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health during the 2nd quarter worth approximately $35,000. Peak Financial Advisors LLC acquired a new stake in shares of CVS Health during the 2nd quarter worth approximately $1,022,000. Roxbury Financial LLC grew its stake in shares of CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 202 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. grew its stake in shares of CVS Health by 11.0% during the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 12,053 shares of the pharmacy operator’s stock worth $832,000 after purchasing an additional 1,195 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Activity at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the transaction, the director owned 22,156 shares in the company, valued at $1,573,519.12. The trade was a 25.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Trading Up 0.4%

Shares of CVS stock opened at $75.00 on Monday. The stock’s fifty day moving average is $67.11 and its two-hundred day moving average is $66.33. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The firm has a market capitalization of $95.12 billion, a P/E ratio of 20.95, a PEG ratio of 0.83 and a beta of 0.62. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $75.55.

CVS Health (NYSE:CVS – Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.35. The company had revenue of $98.92 billion for the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. The ex-dividend date was Tuesday, July 22nd. CVS Health’s payout ratio is currently 74.30%.

Analyst Ratings Changes

A number of brokerages have recently commented on CVS. Wall Street Zen cut shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday. Bernstein Bank dropped their price objective on shares of CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a research note on Wednesday, July 16th. Zacks Research cut shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 8th. Jefferies Financial Group lifted their price target on shares of CVS Health from $74.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, June 30th. Finally, Morgan Stanley lifted their price target on shares of CVS Health from $80.00 to $82.00 and gave the company an “overweight” rating in a research note on Friday, August 1st. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $77.89.

Get Our Latest Research Report on CVS Health

CVS Health Company Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Articles

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).